在癌症免疫治疗中,CD47向治疗的机遇和挑战
Qiuqiang Chen1, Xuejun Guo2, Wenxue Ma3
1Key Laboratory for Translational Medicine, The First Affiliated Hospital, Huzhou University School of Medicine, Huzhou, 313000, China.
Oncology research
|January 8, 2024
概括
CD47是瘤微环境中的关键调节剂,影响癌症免疫治疗的有效性. 针对CD47提供了一种有希望的策略,可以提高癌症治疗结果,尽管存在耐药性和毒性等挑战.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 细胞生物学 细胞生物学
背景情况:
- 瘤微环境 (TME) 极大地影响了癌症免疫疗法的疗效.
- 细胞表面蛋白CD47被认为是TME中的重要调节者.
- 了解CD47的作用对于推进癌症治疗策略至关重要.
研究的目的:
- 综合审查CD47在TME调节和免疫逃避中的多方面的作用.
- 阐明CD47对各种免疫治疗结果的影响,包括检查点抑制剂和CAR T细胞疗法.
- 探索当前和潜在的CD47向疗法用于癌症治疗.
主要方法:
- 关于CD47在癌症免疫治疗中的现有研究的文献综述.
- 在TME内对CD47在免疫逃避中的机制的分析.
- 讨论涉及CD47.7的临床影响和治疗策略.
主要成果:
- CD47在调节TME内的免疫反应方面发挥着至关重要的作用.
- 针对CD47的疗法在改善各种癌症免疫疗法的结果方面表现有前途.
- 挑战包括潜在的毒性,耐药性和对健康细胞的影响.
结论:
- CD47是增强癌症免疫疗法的重要治疗标.
- 需要结合方法和进一步的研究来克服耐药性和优化CD47向疗法.
- 应对挑战对于实现基于CD47的癌症治疗的全部潜力至关重要.
相关概念视频
01:27Tumor Immunotherapy
527
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
527
02:57Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
02:50Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
01:30Cancer Vaccines
368
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
368